Stock listing

NASDAQ:RETA Reata Pharmaceuticals Inc Stock

Follow Reata Pharmaceuticals Inc into a list and get an email when it puts out news.

Last close · NASDAQ:RETA

$172.36 USD

Close on Sep 26, 2023 · No longer trades

May 26, 2016 to last close +1,219% · weekly closes, May 26, 2016 – Sep 26, 2023
Lowest – highest close
$13.07 – $247.74 USDSince May 26, 2016 · lowest May 26, 2016 · highest Feb 4, 2020

Delisted NASDAQ:RETA no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:RETA
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Reata Pharmaceuticals Inc on 6ix

Calls
10 calls with a replay · 10 with a transcript · latest May 10, 2023
Decks
24 decks · latest May 10, 2023

Events

Open Events

Decks

DeckKindSlidesDate
Q1 2023 Earnings PresentationEarnings36 slidesMay 10, 2023
Corporate Update (February 2023)Corporate update33 slidesFeb 28, 2023
Q3 2022 Earnings PresentationEarnings23 slidesNov 8, 2022
Q2 2022 Earnings PresentationEarnings30 slidesAug 8, 2022
Q1 2022 Earnings PresentationEarnings29 slidesMay 10, 2022
FY2021 Earnings PresentationEarnings25 slidesFeb 28, 2022
Q3 2021 Earnings PresentationEarnings17 slidesNov 8, 2021
Q2 2021 Earnings PresentationEarnings23 slidesAug 9, 2021
Q1 2021 Earnings PresentationEarnings36 slidesMay 6, 2021
FY2020 Earnings PresentationEarnings48 slidesMar 1, 2021
All 24 decks
DeckKindSlidesDate
Investor Presentation (January 2021)Investor deck53 slidesJan 11, 2021
Q3 2020 Earnings PresentationEarnings41 slidesNov 9, 2020
Corporate Update (November 2019)Corporate update17 slidesNov 12, 2019
Corporate Update (October 2019)Corporate update15 slidesOct 15, 2019
Q2 2019 Earnings PresentationEarnings15 slidesAug 8, 2019
Corporate Update (September 2018)Corporate update16 slidesSep 25, 2018
Corporate Update (July 2018)Corporate update22 slidesJul 23, 2018
Technical Presentation (May 2018)Technical5 slidesMay 25, 2018
Corporate Update (May 2018)Corporate update15 slidesMay 25, 2018
Technical Presentation (November 2017)Technical30 slidesNov 6, 2017
2017 American Society of Nephrology MeetingConference12 slidesNov 3, 2017
Technical Presentation (July 2017)Technical13 slidesJul 24, 2017
Technical Presentation (June 2017)Technical23 slidesJun 2, 2017
Technical Presentation (June 2017)Technical13 slidesJun 2, 2017

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Christy Oliger
Other companies: Zenas BioPharma, Inc. (Director · Since at least Aug 13, 2026); Bicara Therapeutics Inc. (Director · Since at least Jul 28, 2026); Nuvalent, Inc. (Director · Since at least Jun 18, 2025); LAVA Therapeutics NV (Director · Since at least Jan 1, 2025); Vera Therapeutics, Inc. (Director · Since at least Jun 7, 2024); Replimune Group, Inc. (Director · Since at least Dec 1, 2021); Karyopharm Therapeutics Inc. (Director · Since at least Aug 28, 2020); RayzeBio, Inc. (Director · Sep 14, 2023 – Feb 26, 2024 · Past); Sierra Oncology Inc (Director · Jun 2, 2021 – Jul 1, 2022 · Past)
Director · Apr 15, 2021 – Sep 26, 2023 · Past
Rajiv Patni
Other companies: Septerna, Inc. (Chief Medical Officer · Since at least Aug 24, 2026); BioXcel Therapeutics, Inc. (Director · Since at least Jan 15, 2025); Quince Therapeutics, Inc. (Director · Since at least Feb 15, 2024); Portola Pharmaceuticals Inc (EVP, CMO · Feb 3, 2020 – Jul 2, 2020 · Past); Adamas Pharmaceuticals Inc (Chief Medical Officer · Jun 8, 2015 – Apr 8, 2019 · Past); Ocera Therapeutics Inc (Chief Development Officer · Sep 2, 2014 – May 7, 2015 · Past)
EVP, Chief R&D Officer · Jun 12, 2023 – Sep 26, 2023 · Past
R Kent McGaughy Jr
Other companies: Instil Bio, Inc. (Director · Since at least Mar 18, 2021); Apollo Endosurgery Inc (Director · Dec 29, 2016 – Apr 4, 2023 · Past)
Director · May 25, 2016 – Sep 26, 2023 · Past
Steven Ryder
Other companies: MBX Biosciences, Inc. (Director · Since at least Sep 12, 2024); Rallybio Corporation (Chief Medical Officer · Jul 29, 2021 – Feb 14, 2025 · Past)
Director · Jul 11, 2022 – Sep 26, 2023 · Past
Bhaskar Anand
Other companies: Summit Therapeutics Inc. (Chief Accounting Officer · Since at least Apr 2, 2024)
SVP, Chief Accounting Officer · Nov 13, 2021 – Sep 26, 2023 · Past
Shamim Ruff
Other companies: Sarepta Therapeutics, Inc. (SVP, Chief Regulatory Affairs · Oct 3, 2017 – May 22, 2018 · Past)
Director · Apr 15, 2021 – Sep 26, 2023 · Past
Andrea LoewenSVP, Global Regulatory Affairs · Feb 7, 2022 – Sep 26, 2023 · Past
Dennis K StoneDirector · May 25, 2016 – Dec 7, 2016 · Past
Elaine CastellanosVP, Chief Accounting Officer · Apr 8, 2019 – Jun 7, 2021 · Past
James Warren HuffChief Executive Officer, Director · May 25, 2016 – Sep 26, 2023 · Past
All 11 people
PersonSeat
William RoseDirector · May 25, 2016 – Sep 26, 2023 · Past

Open People

Log in to ask 6ix AI your own questions about Reata Pharmaceuticals Inc.